These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16224827)

  • 21. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?
    Abril B; Carlander B; Touchon J; Dauvilliers Y
    Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-hydroxybutyric acid: a neurotransmitter, a medicine, a drug of abuse. Proceedings of the 8th Congress of the Italian Society on Biological Psychiatry. Naples, Italy, September 29-October 3, 1998.
    Alcohol; 2000 Apr; 20(3):215-304. PubMed ID: 10950505
    [No Abstract]   [Full Text] [Related]  

  • 24. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    Elsing C; Stremmel W; Grenda U; Herrmann T
    Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma-hydroxybutyric acid.
    Zvosec DL; Smith SW
    N Engl J Med; 2005 Oct; 353(15):1632-3. PubMed ID: 16224826
    [No Abstract]   [Full Text] [Related]  

  • 28. Gamma-hydroxybutyric acid.
    Sass JO; Superti-Furga A
    N Engl J Med; 2005 Oct; 353(15):1632-3. PubMed ID: 16221793
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel high-affinity and selective biaromatic 4-substituted gamma-hydroxybutyric acid (GHB) analogues as GHB ligands: design, synthesis, and binding studies.
    Høg S; Wellendorph P; Nielsen B; Frydenvang K; Dahl IF; Bräuner-Osborne H; Brehm L; Frølund B; Clausen RP
    J Med Chem; 2008 Dec; 51(24):8088-95. PubMed ID: 19053823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of gamma-hydroxybutyric acid in serum and urine by headspace solid-phase dynamic extraction combined with gas chromatography-positive chemical ionization mass spectrometry.
    Lenz D; Kröner L; Rothschild MA
    J Chromatogr A; 2009 May; 1216(18):4090-6. PubMed ID: 19327780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recognition and treatment of gamma hydroxybutyric acid poisoning].
    Seubert ME
    Ned Tijdschr Geneeskd; 2004 Jul; 148(28):1410-1; author reply 1411. PubMed ID: 15291428
    [No Abstract]   [Full Text] [Related]  

  • 32. [Convulsions in a case of tetanus treated with gamma-OH and neuroleptoanalgesia].
    De Luca G; Agresta P
    Rass Int Clin Ter; 1966 Oct; 46(20):1156-8. PubMed ID: 5998907
    [No Abstract]   [Full Text] [Related]  

  • 33. GABAergic medications for treating alcohol dependence.
    Caputo F; Vignoli T; Francini S; Stoppo M; Bernardi M
    J Clin Psychopharmacol; 2007 Oct; 27(5):539-40; author reply 540-2. PubMed ID: 17873704
    [No Abstract]   [Full Text] [Related]  

  • 34. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
    Lenz D; Rothschild MA; Kröner L
    Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narcolepsy--master of disguise: evidence-based recommendations for management.
    Mohsenin V
    Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics and treatment of narcolepsy.
    Dauvilliers Y; Tafti M
    Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
    Mamelak M
    Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil in the treatment of narcolepsy.
    Niederhofer H
    J Clin Sleep Med; 2006 Jan; 2(1):71-2. PubMed ID: 17557440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of D-glucuronate to enhance gamma-hydroxybutyric acid metabolism during gamma-hydroxybutyric acid toxicity: pharmacokinetic and pharmacodynamic studies.
    Bhattacharya I; Boje KM
    Biopharm Drug Dispos; 2007 Jan; 28(1):1-11. PubMed ID: 17061294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.